CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy
Sign Up to like & getrecommendations! Published in 2025 at "Cancers"
DOI: 10.3390/cancers17183058
Abstract: Simple Summary Patients with unresectable hepatocellular carcinoma (HCC) often receive immune checkpoint inhibitors, but early identification of responders remains challenging. The established CRAFITY score combines C-reactive protein and alpha-fetoprotein (AFP) at baseline, yet its prognostic… read more here.
Keywords: immunotherapy; hepatocellular carcinoma; afp pivka; crafity afp ... See more keywords